919 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
5 Drug Stocks in Focus on World MS Day http://www.zacks.com/stock/news/262510/5-drug-stocks-in-focus-on-world-ms-day?cid=CS-ZC-FT-262510 May 31, 2017 - Life with MS -- this world MS day, here's a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market.
3 Top Dividend Stocks in Generic Drugs https://www.fool.com/investing/2017/05/26/3-top-dividend-stocks-in-generic-drugs.aspx?source=iedfolrf0000001 May 26, 2017 - Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry.
3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter https://www.fool.com/investing/2017/05/22/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?source=iedfolrf0000001 May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
Teva: What's Going On? https://seekingalpha.com/article/4075098-teva-going?source=feed_tag_israel May 22, 2017 - How did Teva perform in Q1?How's the plan of deleveraging going?Should you wait to buy until after Allergan dumps their shares?
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab http://www.zacks.com/stock/news/261265/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab?cid=CS-ZC-FT-261265 May 19, 2017 - Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA http://www.zacks.com/stock/news/261243/valeant-vrx-decides-to-extend-stay-on-xifaxans-anda?cid=CS-ZC-FT-261243 May 19, 2017 - Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva's ANDA for a generic version of Xifaxan 550 mg tablets.
Vanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, ... http://www.gurufocus.com/news/522202/vanguard-health-care-fund-buys-abbott-laboratories-tesaro-inc-teva-pharmaceutical-industries-sells-st-jude-medical-inc-incyte-corp-amgen-inc May 16, 2017 - Vanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, Sells St Jude Medical Inc, Incyte Corp, Amgen Inc, Stocks: ABT,TEVA,IONS,CTEC,01177,APN,TSRO,PTHN,CNC,HUM,INC, release date:May 16, 2017
County in New York goes after J&J, Teva and Endo for fraudulent marketing of opioids https://seekingalpha.com/news/3267773-county-new-york-goes-j-and-j-teva-endo-fraudulent-marketing-opioids?source=feed_news_all May 16, 2017 - Reuters reports that Orange County, New York has filed a lawsuit against Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries (NYSE:TEVA), Endo International (NASDAQ:ENDP) and other drug m
Third Time Is Not the Charm for PPG as Azko Nobel Rejects Another Offer https://www.fool.com/investing/2017/05/16/third-times-the-charm-as-azko-nobel-agrees-to-cons.aspx?source=iedfolrf0000001 May 16, 2017 - Coatings specialist doesn't seem to know how to take "No" for an answer.
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka http://www.zacks.com/stock/news/260741/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka?cid=CS-ZC-FT-260741 May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.

Pages: 1...7778798081828384858687...92

<<<Page 82>